Protalix BioTherapeutics Inc (PLX)
1.335
+0.08
(+6.80%)
USD |
NYAM |
Nov 04, 13:14
Protalix BioTherapeutics Total Assets (Quarterly): 91.54M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 91.54M |
| March 31, 2024 | 89.82M |
| December 31, 2023 | 84.43M |
| September 30, 2023 | 87.57M |
| June 30, 2023 | 88.42M |
| March 31, 2023 | 66.56M |
| December 31, 2022 | 55.79M |
| September 30, 2022 | 56.71M |
| June 30, 2022 | 60.64M |
| March 31, 2022 | 68.39M |
| December 31, 2021 | 73.66M |
| September 30, 2021 | 83.48M |
| June 30, 2021 | 108.20M |
| March 31, 2021 | 102.79M |
| December 31, 2020 | 67.93M |
| September 30, 2020 | 72.31M |
| June 30, 2020 | 71.71M |
| March 31, 2020 | 82.88M |
| December 31, 2019 | 45.39M |
| September 30, 2019 | 53.73M |
| June 30, 2019 | 55.24M |
| March 31, 2019 | 61.04M |
| December 31, 2018 | 61.13M |
| September 30, 2018 | 67.20M |
| June 30, 2018 | 51.72M |
| Date | Value |
|---|---|
| March 31, 2018 | 64.80M |
| December 31, 2017 | 72.21M |
| September 30, 2017 | 61.06M |
| June 30, 2017 | 59.00M |
| March 31, 2017 | 71.85M |
| December 31, 2016 | 82.25M |
| September 30, 2016 | 70.47M |
| June 30, 2016 | 78.86M |
| March 31, 2016 | 87.31M |
| December 31, 2015 | 97.25M |
| September 30, 2015 | 59.49M |
| June 30, 2015 | 65.95M |
| March 31, 2015 | 72.05M |
| December 31, 2014 | 78.36M |
| September 30, 2014 | 84.80M |
| June 30, 2014 | 96.65M |
| March 31, 2014 | 103.42M |
| December 31, 2013 | 113.33M |
| September 30, 2013 | 121.16M |
| June 30, 2013 | 62.31M |
| March 31, 2013 | 69.94M |
| December 31, 2012 | 78.73M |
| September 30, 2012 | 77.38M |
| June 30, 2012 | 84.30M |
| March 31, 2012 | 68.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.39M
Minimum
Dec 2019
108.20M
Maximum
Jun 2021
76.75M
Average
73.66M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Aethlon Medical Inc | 11.42M |
| Predictive Oncology Inc | 10.59M |
| bluebird bio Inc | 545.19M |
| AIM ImmunoTech Inc | 15.72M |
| Armata Pharmaceuticals Inc | 108.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.96M |
| Shareholders Equity (Quarterly) | 28.58M |
| Debt to Equity Ratio | 0.7145 |
| Current Ratio | 1.335 |
| Net Debt Paydown Yield | 1.83% |